Hemostatic Agents Market Trends 2025–2029: Forecasts for Key Growth Segments

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

By How Much Is The Hemostatic Agents Market Expected To Expand Between 2025 And 2029?

The hemostatic agents market has experienced robust growth in recent years. It is projected to expand from $4.19 billion in 2024 to $4.42 billion in 2025, achieving a compound annual growth rate (CAGR) of 5.5%. This historical expansion can be attributed to an aging global population, an increase in trauma and accident cases, the rising prevalence of cardiovascular disorders, a higher incidence of bleeding disorders such as hemophilia, and a growing number of patients with liver diseases and coagulation defects.

The hemostatic agents market is projected for significant expansion over the coming years, reaching a valuation of $5.43 billion by 2029, driven by a compound annual growth rate (CAGR) of 5.3%. This anticipated growth during the forecast period is primarily due to several factors, including a rise in the volume of surgical procedures, an expansion in minimally invasive surgical techniques, an escalating demand for orthopedic interventions, an increase in cosmetic and aesthetic surgical operations, and the critical requirement for hemostasis during dental surgeries. Key trends influencing the market in this period encompass notable advancements in hemostatic agent formulations, the emergence of bioengineered and recombinant agents, improvements in product shelf-life and stability, the creation of combination products, and the ongoing development of synthetic and absorbable hemostats.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25780&type=smp

What Are The Top Growth Drivers Impacting The Hemostatic Agents Market Outlook?

The hemostatic agents market is anticipated to expand due to the rising volume of surgical procedures in the future. These procedures involve medical operations carried out by health professionals with specific tools to treat, mend, or extract body parts for health reasons. A significant factor in this increase is the growing prevalence of chronic conditions, frequently requiring surgery to address health concerns and enhance patient results. Hemostatic agents play a crucial role during surgeries by promptly halting bleeding, thereby lessening blood loss and improving the surgeon’s view in the operating field for greater precision. For example, in March 2023, data from the British Association of Aesthetic Plastic Surgeons (BAAPS), a professional body based in the UK, indicated that 31,057 cosmetic procedures were performed in 2022, marking a 102% surge compared to the prior year. Furthermore, women accounted for 93% of these procedures, representing a 101% increase from 2021. Consequently, the rising volume of surgical interventions is propelling the expansion of the hemostatic agents market.

What Are The Primary Types Of Segments Analyzed In The Hemostatic Agents Market?

The hemostatic agents market covered in this report is segmented –

1) By Type: Thrombin-Based Hemostats, Gelatin-Based Hemostats, Collagen-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Combination Hemostats, Fibrin Sealants, Other Types

2) By Application: Trauma, Cardiovascular Surgery, General Surgery, Plastic Surgery, Orthopedic Surgery, Neurosurgery, Other Applications

3) By End-User: Hospitals, Surgery Centers, Nursing Homes, Other End Users

Subsegments:

1) By Thrombin-Based Hemostats: Bovine Thrombin, Human Thrombin, Poxidized Regenerated Cellulose (Orc)Ine Thrombin, Combined Thrombin Products

2) By Gelatin-Based Hemostats: Absorbable Gelatin Sponges, Gelatin Powder, Gelatin Paste, Gelatin With Thrombin

3) By Collagen-Based Hemostats: Collagen Sponges, Collagen Powder, Collagen With Thrombin, Collagen Sheets Or Patches

4) By Oxidized Regenerated Cellulose-Based Hemostats: Oxidized Regenerated Cellulose (ORC) Pads, Oxidized Regenerated Cellulose (ORC) Mesh, Oxidized Regenerated Cellulose (ORC) Powder, Oxidized Regenerated Cellulose (ORC) With Other Active Agents

5) By Combination Hemostats: Gelatin And Thrombin Combinations, Collagen And Thrombin Combinations, Oxidized Regenerated Cellulose (ORC) And Thrombin Combinations, Multi-Agent Combinations

6) By Fibrin Sealants: Human Plasma-Derived Fibrin Sealants, Recombinant Fibrin Sealants, Sprayable Fibrin Sealants, Liquid Fibrin Sealants, Fibrin Sealants With Antimicrobials

7) By Other Types: Polysaccharide-Based Hemostats, Synthetic Polymer-Based Hemostats, Microfibrillar Collagen Hemostats, Chitosan-Based Hemostats, Calcium-Based Hemostats

Which Key Trends Are Expected To Influence The Hemostatic Agents Market In The Coming Years?

Major companies in the hemostatic agents market are prioritizing the development of advanced solutions, such as collagen-based hemostats, to deliver rapid and effective control of bleeding and tissue closure for both open and minimally invasive surgeries. Collagen-based hemostats are hemostatic materials extracted from purified collagen that aid in stopping bleeding by enhancing the body’s natural clotting capabilities at the site of a wound or surgical incision. For instance, in March 2025, Baxter, a US-based healthcare company, launched HEMOPATCH Sealing Hemostat, an absorbable pad based on collagen. This sophisticated collagen-based pad utilizes a dual-action mechanism combining a collagen matrix with an NHS-PEG layer that forms a hydrogel upon contact with moisture, allowing for swift sealing of bleeding sites. It offers strong adhesion to wet tissues, rendering it suitable for both open and minimally invasive surgeries where other agents might prove less effective. The patch provides hemostasis in under two minutes without requiring temperature-controlled storage or special preparation, thereby streamlining surgical processes. It also naturally dissolves in the body within 6 to 8 weeks and can be stored at room temperature for up to three years, thereby meeting important clinical and storage requirements.

Who Are The Primary Competitors In The Global Hemostatic Agents Market?

Major companies operating in the hemostatic agents market are Pfizer Inc., Johnson & Johnson Services Inc., Becton, Dickinson & Co., CSL Ltd., Baxter International Inc., Teleflex Inc., Integra LifeSciences Holdings Corp., Gelita Medical, Artivion Inc., B. Braun Melsungen AG, Advanced Medical Solutions Group Plc, Z-Medica, Marine Polymer Technologies Inc., MedTrade Products Ltd., Samyang Holdings Corp., Vascular Solutions Pc, BioCer Entwicklungs GmbH, Starch Medical Inc., Arch Therapeutics Inc., Medcura Inc., Biom’Up SAS.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/hemostatic-agents-global-market-report

How Does The Hemostatic Agents Market Perform Across Key Geographic Regions?

North America was the largest region in the hemostatic agents market in 2024. The regions covered in the hemostatic agents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Hemostatic Agents Market Report:

https://www.thebusinessresearchcompany.com/customise?id=25780&type=smp

Browse Through More Reports Similar to the Global Hemostatic Agents Market 2025, By The Business Research Company

Hemostasis Products Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hemostasis-products-global-market-report

Hemostats Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hemostats-global-market-report

Hematology Drug Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hematology-drug-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795